As an influx of cannabis customers turn to the plant for medicinal purposes, it creates a disruptive trend for the traditional OTC and pharmaceutical drug markets. Here, BDS Analytics shares a sampling of key cannabis insights in an infographic created exclusively for mg (it appeared in the April, 2019 issue), including spending forecasts for both synthetic and naturally derived cannabis-based pharmaceuticals, the state of clinical trials for cannabis-derived drugs, prescription medication usage trends, and more.
Advertisement
